IGF2BP3 and telomere syndrome: Given the paucity of knowledge regarding the molecular landscape of STS and the need for improved prognostication, this study evaluates the expression and prognostic value of IGF2BP3 in a large cohort of STS subtypes across three unique patient datasets.